Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

PageRank interpreted hyperlinks as endorsements, prioritizing pages linked by many others and weighting endorsements from ...

Power first, models second AI is no longer constrained primarily by algorithms or capital; it is constrained by electrons.

15-451/651 is an advanced undergraduate/masters algorithms class. We cover fundamental algorithmic modeling techniques (e.g. dynamic programming, graphs, network flows, linear programming), advanced ...

By David Swanson, World BEYOND War Ah, those were the days. The UN had been blocked by a worldwide popular movement from ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

In a Q&A, Recursion’s incoming CEO acknowledges hype around the idea of using AI to expedite drug development, and says it's ...

This week, my colleagues and I scheduled 30 minutes to talk with Mark Cuban for “The Readout LOUD” podcast. The conversation ...

Ricursive Intelligence, a frontier AI lab with the mission to transform semiconductor design, launched today and announced its $35 million seed round led by Sequoia Capital at a $750 million final ...

Few would place Recursion Pharmaceuticals (NASDAQ: RXRX), a little-known biotech company, in the same league as these tech ...

Nvidia Corporation posts record data center revenue, yet shares dip on AI bubble fears. Click for this updated look at NVDA ...